0 Items - $0.00
A to Z


N6- Benzyladenosine- 3', 5'- cyclic monophosphate ( 6-Bn-cAMP ), sodium salt

Membrane-permeant PKA agonist
Cat. No.: B 008
CAS No.: [32115-08-5]
Shipping: ambient
Product Name Price (net) Qty
Cat. No.: B 008-10
Unit: 10 µmol / ~4.4 mg
For other salt forms or metabolites of 6-Bn-cAMP please inquire. Site-selective activator of cAMP-dependent protein kinase which does not activate Epac. Increased hydrolytic stability against PDE, esterases, amidases and considerably higher membrane permeability compared to cAMP. Detailed technical information and updated reference list available. Reference: Pepe et al., Cancer Res., 51, 6263 - 6267 (1991).
Cat. No. B 008
CAS number [32115-08-5]
Purity > 98% HPLC
Salt form Sodium
Storage temperature -20°C / -4°F
Molecular formula C₁₇H₁₇N₅O₆P · Na
Molecular weight [g/mol] 441,3
Target PKA (cAK) Activator
Lipophilicity 2.43
Absorption max [nm] 268
Molar extinction coefficient ε [L·mol⁻¹·cm⁻¹] 20500
  • 1. Schwede F., Bertinetti D., Langerijs C. N., Hadders M. A., Wienk H., Ellenbroek J. H., de Koning E. J. P., Bos J. L., Herberg F. W., Genieser H.-G., Janssen R. A.Rehmann H., PLoS Biol., 13, 1 - 26 (2015), "Structure-Guided Design of Selective Epac1 and Epac2 Agonists"
  • 2. Chepurny O. G., Bertinetti D., Diskar M., Leech C. A., Afshari P., Tsalkova T., Cheng X., Schwede F., Genieser H.-G., Herberg F. W.Holz G. G., Mol. Endocrinol., 27, 1267 - 1282 (2013), "Stimulation of Proglucagon Gene Expression by Human GPR119 in Enteroendocrine L-cell Line GLUTag"
  • 3. Jäger R., Russwurm C., Schwede F., Genieser H.-G., Koesling D.Russwurm M., J. Biol. Chem., 287, 1210 - 1219 (2012), "Activation of PDE10 and PDE11 Phosphodiesterases"
  • 4. Genieser H.-G., Bos J. L., Christensen A. E., Doeskeland S. O., Havemann U., Manzau U., Rehmann H.Schwede F., Poster #THP016 Montreal, 12, 0 - 0 (2004), "Analogues of Cyclic AMP to Distinguish Between PKA and Epac"
  • 5. Schwede F., Maronde E., Genieser H.-G.Jastorff B., Pharmacol. Ther., 87, 199 - 226 (2000), "Cyclic Nucleotide Analogs as Biochemical Tools and Prospective Drugs"
  • 6. Cho-Chung Y. S., Jastorff B.Genieser H.-G., USA patent 5916, 843, 0 - 0 (1998), "Cyclic AMP Analogues, Individually and in Pairs, to Inhibit Neoplastic Cell Growth"
  • 7. Cho-Chung Y. S.Robins R. K., United States Patent 5752 of August 11, 792, 0 - 0 (1998), "8-Chloro cAMP and Related cAMP Compounds as Antineoplastic Agents"
  • 8. Zorn M., Fladmark K. E., Oegreid D., Jastorff B., Doeskeland S. O.Dostmann W. R. G., FEBS Lett., 362, 291 - 294 (1995), "Ala 335 is Essential for High-affinity cAMP-binding of Both Sites A and B of cAMP-dependent Protein Kinase Type I"
  • 9. Newton R. P., Bayliss M. A., Wilkins A. C. R., Games D. E., Brenton A. G., Langridge J. L., Walton T. J.Harris F. M., J. Mass Spectrometry, 0, 107 - 110 (1995), "Fast Atom Bombardement Mass Spectrometric Analysis of Cyclic Nucleotide Analogues Used in Studies of Cyclic Nucleotide-dependent Protein Kinases"
  • 10. Tortora G., Budillon A., Yokozaki H., Clair T., Pepe S., Merlo G., Rohlff C.Cho-Chung Y. S., Cell Growth Differ., 5, 753 - 759 (1994), "Retroviral Vector-mediated Overexpression of the R IIß Subunit of the cAMP-dependent Protein Kinase Induces Differentiation in Human Leukemia Cells and Reverts the Transformed Phenotype of Mouse Fibroblasts"
  • 11. Cho-Chung Y. S.Clair T., Pharmacol. Ther., 60, 265 - 288 (1993), "The Regulatory Subunit of cAMP-dependent Protein Kinase as a Target for Chemotherapy of Cancer and Other Cellular Dysfunctional-related Diseases"
  • 12. Zorn M., Maronde E., Jastorff B.Richter-Landsberg C., Eur. J. Cell Biol., 60, 351 - 357 (1993), "Differential Effects of Two Structurally Related N6-substituted cAMP Analogues on C6 Glioma Cells"
  • 13. Rohlff C., Clair T.Cho-Chung J. S., J. Biol. Chem., 268, 5774 - 5782 (1993), "8-Cl-cAMP Induces Truncation and Down-Regulation of the RI(Alpha) Subunit and Up-Regulation of the RII(Beta) Subunit of cAMP-Dependent Protein Kinase Leading to Type II Holoenzyme-Dependent Growth Inhibition and Differentiation of HL-60 Leukemia Cells"
  • 14. Langeveld C. H., Jongenelen C. A. M., Heimans J. J.Stoof J. C., Cancer Res., 52, 3994 - 3999 (1992), "Growth Inhibition of Human Glioma Cells Induced by 8-Chloroadenosine, an Active Metabolite of 8-Chloro Cyclic Adenosine 3':5'- Monophosphate"
  • 15. Taylor C. W.Yeoman L. C., Anti-Cancer Drug, 3, 485 - 491 (1992), "Inhibition of Colon Tumor Cell Growth by 8 Chloro cAMP is Independent Upon its Conversion to 8-Chloroadenosine"
  • 16. Cho-Chung Y. S., Biochem. Soc. Trans., 20, 425 - 429 (1992), "Suppression of Malignancy Targeting Cyclic AMP Signal Transducing Proteins"
  • 17. Van Lookeren Campagne M. M., Diaz F. V., Jastorff B.Kessin R. H., Cancer Res., 51, 1600 - 1605 (1991), "8-Chloroadenosine 3',5'-Monophosphate Inhibits the Growth of Chinese Hamster Ovary and Molt-4 Cells Through its Adenosine Metabolite"
  • 18. Pepe S., Tortora G., Noguchi P. D., Marti G. E., Washington G. C.Cho-Chung Y. S., Cancer Res., 51, 6263 - 6267 (1991), "Effects of 8-Chloradenosine 3´,5´-Monophosphate and N6-Benzyl-Cyclic Adenosine 5´-Monophosphate on Cell Cycle Kinetics of HL-60 Leukemia Cells"
  • 19. Ciardiello F., Tortora G., Kim N., Clair T., Ally S., Salomon D. S.Cho-Chung Y. S., J. Biol. Chem., 265, 1016 - 1020 (1990), "8-Chloro-cAMP Inhibits Transforming Growth Factor A Transformation of Mammary Epithelial Cells by Restoration of the Normal mRNA Patterns for cAMP- dependent Protein Kinase Regulatory Subunit Isoforms Which Show Disruption upon Transformation"
  • 20. Cho-Chung Y. S., Clair T., Tagliaferri P., Ally S., Katsaros D., Tortora G., Neckers L. M., Avery T. L., Crabtree G. W.Robins R. K., Cancer Invest., 7, 161 - 177 (1989), "Site-selective Cyclic AMP Analogs as New Biological Tools in Growth Control, Differentiation, and Proto-oncogene Regulation"
  • 21. Cho-Chung Y. S., US Patent Application 198489, 15, 0 - 0 (1989), "Sites 1- and 2-selective cAMP Derivatives as Neoplasm Inhibitors"
  • 22. Tortora G., Tagliaferri P., Clair T., Colamonici O., Neckers L. M., Robins R. K.Cho-Chung J.-S., Blood, 71, 230 - 233 (1988), "Site-selective Cyclic AMP Analogs at Micromolar Concentrations Induce Growth Arrest and Differentiation of Acute Promyelocytic, Chronic Myelocytic, and Acute Lymphocytic Human Leukemia Cell Lines"
  • 23. Tagliaferri P., Katsaros D., Clair T., Ally S., Tortora G., Neckers L. M., Rubalcava B., Parandoosh Z., Chang Y.-A., Revankar G. R., Crabtree G. W., Robins R. K.Cho-Chung Y. S., Cancer Res., 48, 1642 - 1650 (1988), "Synergistic Inhibition of Growth of Breast and Colon Human Cancer Cell Lines by Site-selective Cyclic AMP Analogs"
  • 24. Katsaros D., Tortora G., Tagliaferri P., Clair T., Ally S., Neckers L. M., Robins R. K.Cho-Chung Y. S., FEBS Lett., 223, 97 - 103 (1987), "Site-selective Cyclic AMP Analogs Provide a New Approach in the Control of Cancer Cell Growth"
  • 25. Ebright R. H., Le Grice S. F. J., Miller J. P.Krakow J. S., J. Mol. Biol., 182, 91 - 107 (1985), "Analogs of Cyclic AMP that Elicit the Biochemically Defined Conformational Change in Catabolite Gene Activator Protein (CAP) but do not Stimulate Binding to DNA"
  • 26. Oegreid D., Doeskeland S. O.Miller J. P., J. Biol. Chem., 258, 1041 - 1049 (1983), "Evidence That Cyclic Nucleotides Activating Rabbit Muscle Protein Kinase I Interact with Both Types of cAMP Binding Sites Associated with the Enzyme"
  • 27. Miller J. P., Adv. Cyclic Nucl. Res., 14, 335 - 344 (1981), "Cyclic AMP Derivatives as Tools for Mapping Cyclic AMP Binding Sites of Cyclic AMP-dependent Protein Kinases I and II"
  • 28. Zimmerman T. P., Biochem. Pharmacol., 28, 2533 - 2539 (1979), "Nucleoside 3',5'- Cyclic Monophosphate Metabolites of Purine Analogs"
  • 29. Hong C. I., Tritsch G. L., Mittelman A., Hebborn P.Chheda G. B., J. Med. Chem., 18, 465 - 473 (1975), "Synthesis and Antitumor Activity of 5'-Phosphates and Cyclic 3', 5' -Phosphates Derived from Biologically Active Nucleosides"
  • 30. Sidwell R. W., Huffman J. H., Allen L. B., Meyer R. B., Shuman D. A., Simon L. N.Robins R. K., Antimicrob. Agents and Chemother., 5, 652 - 657 (1974), "In Vitro Antiviral Activity of 6-Substituted 9-ß-D-Ribofuranosylpurine 3',5'- Cyclic Phosphates"

Show more